Related Articles
Suppression of renal cell carcinoma growth in vivo by forced expression of vascular endothelial growth inhibitor
Epigenetic modulators hydralazine and sodium valproate act synergistically in VEGI-mediated anti-angiogenesis and VEGF interference in human osteosarcoma and vascular endothelial cells
Vascular endothelial growth inhibitor in human cancer (Review)
VEGI downregulation is correlated with nodal metastasis and poor prognosis in lung adenocarcinoma
Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells